$CPHD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CEPHEID.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CEPHEID. Get notifications about new insider transactions in CEPHEID for free.
Page: < prev 1 ... 11 12 13 14 15 16 17 18 19 ... 19 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 11 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Option Exercise | M | 2.92 | 5,000 | 14,600 | 5,000 | |
| Jan 11 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Gift | G | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Jan 11 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Gift | G | 0.00 | 5,000 | 0 | 73,676 | 78.7 K to 73.7 K (-6.36 %) |
| Jan 11 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Buy | M | 2.92 | 5,000 | 14,600 | 78,676 | 73.7 K to 78.7 K (+6.79 %) |
| Jan 05 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Jan 05 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | A | 34.01 | 90,000 | 3,060,900 | 90,000 | |
| Dec 29 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 33.16 | 3,000 | 99,490 | 764,300 | 767.3 K to 764.3 K (-0.39 %) |
| Dec 29 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Gift | G | 0.00 | 700 | 0 | 767,300 | 768 K to 767.3 K (-0.09 %) |
| Nov 29 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 31.66 | 3,000 | 94,973 | 768,000 | 771 K to 768 K (-0.39 %) |
| Nov 14 2011 | CPHD | CEPHEID | STEELE GLENN JR MD PHD | Director | Grant | A | 33.61 | 254 | 8,537 | 254 | 0 to 254 |
| Nov 14 2011 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Grant | A | 33.61 | 479 | 16,099 | 181,002 | 180.5 K to 181 K (+0.27 %) |
| Nov 14 2011 | CPHD | CEPHEID | Brown Thomas D | Director | Grant | A | 33.61 | 449 | 15,091 | 17,351 | 16.9 K to 17.4 K (+2.66 %) |
| Nov 01 2011 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | M | 0.00 | 313 | 0 | 3,125 | |
| Nov 01 2011 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | M | 0.00 | 312 | 0 | 3,438 | |
| Nov 01 2011 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Sell | S | 37.89 | 83 | 3,145 | 5,403 | 5.5 K to 5.4 K (-1.51 %) |
| Nov 01 2011 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Buy | M | 0.00 | 313 | 0 | 5,486 | 5.2 K to 5.5 K (+6.05 %) |
| Nov 01 2011 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Sell | S | 37.76 | 115 | 4,342 | 5,173 | 5.3 K to 5.2 K (-2.17 %) |
| Nov 01 2011 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Buy | M | 0.00 | 312 | 0 | 5,288 | 5 K to 5.3 K (+6.27 %) |
| Nov 01 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 0.00 | 339 | 0 | 3,386 | |
| Nov 01 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 0.00 | 338 | 0 | 3,725 | |
| Nov 01 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Sell | S | 37.89 | 159 | 6,025 | 13,142 | 13.3 K to 13.1 K (-1.20 %) |
| Nov 01 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 0.00 | 339 | 0 | 13,301 | 13 K to 13.3 K (+2.62 %) |
| Nov 01 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Sell | S | 37.76 | 158 | 5,966 | 12,962 | 13.1 K to 13 K (-1.20 %) |
| Nov 01 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 0.00 | 338 | 0 | 13,120 | 12.8 K to 13.1 K (+2.64 %) |
| Nov 01 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 339 | 0 | 3,386 | |
| Nov 01 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 338 | 0 | 3,725 | |
| Nov 01 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 37.89 | 159 | 6,025 | 1,714 | 1.9 K to 1.7 K (-8.49 %) |
| Nov 01 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 339 | 0 | 1,873 | 1.5 K to 1.9 K (+22.10 %) |
| Nov 01 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 37.76 | 158 | 5,966 | 1,534 | 1.7 K to 1.5 K (-9.34 %) |
| Nov 01 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 338 | 0 | 1,692 | 1.4 K to 1.7 K (+24.96 %) |
| Nov 01 2011 | CPHD | CEPHEID | Miller Andrew | SVP, CFO | Option Exercise | M | 0.00 | 1,250 | 0 | 12,500 | |
| Nov 01 2011 | CPHD | CEPHEID | Miller Andrew | SVP, CFO | Option Exercise | M | 0.00 | 1,250 | 0 | 13,750 | |
| Nov 01 2011 | CPHD | CEPHEID | Miller Andrew | SVP, CFO | Sell | S | 37.89 | 584 | 22,128 | 3,832 | 4.4 K to 3.8 K (-13.22 %) |
| Nov 01 2011 | CPHD | CEPHEID | Miller Andrew | SVP, CFO | Buy | M | 0.00 | 1,250 | 0 | 4,416 | 3.2 K to 4.4 K (+39.48 %) |
| Nov 01 2011 | CPHD | CEPHEID | Miller Andrew | SVP, CFO | Sell | S | 37.76 | 584 | 22,052 | 3,166 | 3.8 K to 3.2 K (-15.57 %) |
| Nov 01 2011 | CPHD | CEPHEID | Miller Andrew | SVP, CFO | Buy | M | 0.00 | 1,250 | 0 | 3,750 | 2.5 K to 3.8 K (+50.00 %) |
| Nov 01 2011 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Gift | G | 0.00 | 27,000 | 0 | 771,000 | 798 K to 771 K (-3.38 %) |
| Nov 01 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 0.00 | 271 | 0 | 2,709 | |
| Nov 01 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 0.00 | 270 | 0 | 2,980 | |
| Nov 01 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Sell | S | 37.89 | 127 | 4,812 | 1,370 | 1.5 K to 1.4 K (-8.48 %) |
| Nov 01 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 0.00 | 271 | 0 | 1,497 | 1.2 K to 1.5 K (+22.10 %) |
| Nov 01 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Sell | S | 37.76 | 127 | 4,796 | 1,226 | 1.4 K to 1.2 K (-9.39 %) |
| Nov 01 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 0.00 | 270 | 0 | 1,353 | 1.1 K to 1.4 K (+24.93 %) |
| Nov 01 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 0.00 | 1,250 | 0 | 12,500 | |
| Nov 01 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 0.00 | 1,250 | 0 | 13,750 | |
| Nov 01 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Sell | S | 37.89 | 584 | 22,128 | 21,540 | 22.1 K to 21.5 K (-2.64 %) |
| Nov 01 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 0.00 | 1,250 | 0 | 22,124 | 20.9 K to 22.1 K (+5.99 %) |
| Nov 01 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Sell | S | 37.76 | 584 | 22,052 | 20,874 | 21.5 K to 20.9 K (-2.72 %) |
| Nov 01 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 0.00 | 1,250 | 0 | 21,458 | 20.2 K to 21.5 K (+6.19 %) |
| Nov 01 2011 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Option Exercise | M | 0.00 | 344 | 0 | 3,438 | |
| Nov 01 2011 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Option Exercise | M | 0.00 | 343 | 0 | 3,782 | |
| Nov 01 2011 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Sell | S | 37.89 | 127 | 4,812 | 1,809 | 1.9 K to 1.8 K (-6.56 %) |
| Nov 01 2011 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Buy | M | 0.00 | 344 | 0 | 1,936 | 1.6 K to 1.9 K (+21.61 %) |
| Nov 01 2011 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Sell | S | 37.76 | 126 | 4,758 | 1,592 | 1.7 K to 1.6 K (-7.33 %) |
| Nov 01 2011 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Buy | M | 0.00 | 343 | 0 | 1,718 | 1.4 K to 1.7 K (+24.95 %) |
| Oct 26 2011 | CPHD | CEPHEID | EASTON ROBERT J | Director | Option Exercise | M | 2.92 | 5,000 | 14,600 | 10,000 | |
| Oct 26 2011 | CPHD | CEPHEID | EASTON ROBERT J | Director | Sell | S | 37.74 | 5,000 | 188,700 | 73,676 | 78.7 K to 73.7 K (-6.36 %) |
| Oct 26 2011 | CPHD | CEPHEID | EASTON ROBERT J | Director | Buy | M | 2.92 | 5,000 | 14,600 | 78,676 | 73.7 K to 78.7 K (+6.79 %) |
| Oct 26 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Option Exercise | M | 21.00 | 25,000 | 525,000 | 61,375 | |
| Oct 26 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Sell | S | 38.51 | 11,177 | 430,445 | 2,500 | 13.7 K to 2.5 K (-81.72 %) |
| Oct 26 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Sell | S | 38.12 | 13,823 | 526,893 | 13,677 | 27.5 K to 13.7 K (-50.27 %) |
| Oct 26 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Buy | M | 21.00 | 25,000 | 525,000 | 27,500 | 2.5 K to 27.5 K (+1,000.00 %) |
| Aug 30 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Option Exercise | M | 20.47 | 11,375 | 232,846 | 27,625 | |
| Aug 30 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Option Exercise | M | 21.00 | 13,625 | 286,125 | 86,375 | |
| Aug 30 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Sell | S | 33.67 | 25,000 | 841,645 | 2,500 | 27.5 K to 2.5 K (-90.91 %) |
| Aug 30 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Buy | M | 20.47 | 11,375 | 232,846 | 27,500 | 16.1 K to 27.5 K (+70.54 %) |
| Aug 30 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Buy | M | 21.00 | 13,625 | 286,125 | 16,125 | 2.5 K to 16.1 K (+545.00 %) |
| Jul 28 2011 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Option Exercise | M | 9.18 | 12,500 | 114,750 | 0 | |
| Jul 28 2011 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Sell | S | 37.71 | 12,500 | 471,415 | 1,550 | 14.1 K to 1.6 K (-88.97 %) |
| Jul 28 2011 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Buy | M | 9.18 | 12,500 | 114,750 | 14,050 | 1.6 K to 14.1 K (+806.45 %) |
| Aug 11 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Option Exercise | M | 21.00 | 25,000 | 525,000 | 100,000 | |
| Aug 11 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Sell | S | 33.39 | 3,043 | 101,604 | 2,500 | 5.5 K to 2.5 K (-54.90 %) |
| Aug 11 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Sell | S | 32.74 | 21,957 | 718,967 | 5,543 | 27.5 K to 5.5 K (-79.84 %) |
| Aug 11 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Buy | M | 21.00 | 25,000 | 525,000 | 27,500 | 2.5 K to 27.5 K (+1,000.00 %) |
| Aug 02 2011 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Option Exercise | M | 14.93 | 30,000 | 447,900 | 170,000 | |
| Aug 02 2011 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Sell | S | 38.11 | 8,005 | 305,054 | 1,375 | 9.4 K to 1.4 K (-85.34 %) |
| Aug 02 2011 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Sell | S | 37.41 | 21,995 | 822,747 | 9,380 | 31.4 K to 9.4 K (-70.10 %) |
| Aug 02 2011 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Buy | M | 14.93 | 30,000 | 447,900 | 31,375 | 1.4 K to 31.4 K (+2,181.82 %) |
| Jul 26 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 11.94 | 50,000 | 597,000 | 0 | |
| Jul 26 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 8.21 | 40,000 | 328,400 | 0 | |
| Jul 26 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 9.11 | 80,000 | 728,800 | 0 | |
| Jul 26 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 9.08 | 45,000 | 408,375 | 0 | |
| Jul 26 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 9.21 | 110,000 | 1,013,100 | 0 | |
| Jul 26 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | S | 39.65 | 325,000 | 12,885,373 | 12,782 | -312,218 to 12.8 K (-104.09 %) |
| Jul 26 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 11.94 | 50,000 | 597,000 | 337,782 | 287.8 K to 337.8 K (+17.37 %) |
| Jul 26 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 8.21 | 40,000 | 328,400 | 287,782 | 247.8 K to 287.8 K (+16.14 %) |
| Jul 26 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 9.11 | 80,000 | 728,800 | 247,782 | 167.8 K to 247.8 K (+47.68 %) |
| Jul 26 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 9.08 | 45,000 | 408,375 | 167,782 | 122.8 K to 167.8 K (+36.65 %) |
| Jul 26 2011 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 9.21 | 110,000 | 1,013,100 | 122,782 | 12.8 K to 122.8 K (+860.59 %) |
| Jul 27 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Option Exercise | M | 21.00 | 25,000 | 525,000 | 125,000 | |
| Jul 27 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Option Exercise | M | 21.00 | 25,000 | 525,000 | 150,000 | |
| Jul 27 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Sell | S | 39.56 | 25,000 | 988,883 | 2,500 | 27.5 K to 2.5 K (-90.91 %) |
| Jul 27 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Buy | M | 21.00 | 25,000 | 525,000 | 27,500 | 2.5 K to 27.5 K (+1,000.00 %) |
| Jul 27 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Sell | S | 39.78 | 25,000 | 994,423 | 2,500 | 27.5 K to 2.5 K (-90.91 %) |
| Jul 27 2011 | CPHD | CEPHEID | Miller Andrew | CFO | Buy | M | 21.00 | 25,000 | 525,000 | 27,500 | 2.5 K to 27.5 K (+1,000.00 %) |
| Jul 26 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 19.85 | 30,000 | 595,500 | 15,000 | |
| Jul 26 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Sell | S | 39.85 | 30,000 | 1,195,500 | 1,083 | 31.1 K to 1.1 K (-96.52 %) |
| Jul 26 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 19.85 | 30,000 | 595,500 | 31,083 | 1.1 K to 31.1 K (+2,770.08 %) |
| Jul 05 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 5,000 | 36,900 | 31,750 | |
| Jul 05 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 35.15 | 5,000 | 175,750 | 1,354 | 6.4 K to 1.4 K (-78.69 %) |
| Jul 05 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 5,000 | 36,900 | 6,354 | 1.4 K to 6.4 K (+369.28 %) |
| Jun 30 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 10,000 | 73,800 | 36,750 | |
| Jun 30 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 34.69 | 5,000 | 173,450 | 1,354 | 6.4 K to 1.4 K (-78.69 %) |
| Jun 30 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 34.23 | 5,000 | 171,150 | 6,354 | 11.4 K to 6.4 K (-44.04 %) |
| Jun 30 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 10,000 | 73,800 | 11,354 | 1.4 K to 11.4 K (+738.55 %) |
| Jun 30 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 3.61 | 30,065 | 108,535 | 6,887 | |
| Jun 30 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 3.61 | 19,935 | 71,965 | 36,952 | |
| Jun 30 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Sell | S | 34.00 | 30,065 | 1,022,210 | 20,208 | 50.3 K to 20.2 K (-59.80 %) |
| Jun 30 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 3.61 | 30,065 | 108,535 | 50,273 | 20.2 K to 50.3 K (+148.78 %) |
| Jun 30 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Sell | S | 34.00 | 19,935 | 677,790 | 20,208 | 40.1 K to 20.2 K (-49.66 %) |
| Jun 30 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 3.61 | 19,935 | 71,965 | 40,143 | 20.2 K to 40.1 K (+98.65 %) |
| Jun 22 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 10,000 | 73,800 | 46,750 | |
| Jun 22 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 33.77 | 5,000 | 168,850 | 1,354 | 6.4 K to 1.4 K (-78.69 %) |
| Jun 22 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 33.31 | 5,000 | 166,550 | 6,354 | 11.4 K to 6.4 K (-44.04 %) |
| Jun 22 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 10,000 | 73,800 | 11,354 | 1.4 K to 11.4 K (+738.55 %) |
| Jun 22 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 3.61 | 100,000 | 361,000 | 56,887 | |
| Jun 22 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Sell | S | 33.50 | 50,000 | 1,675,000 | 20,208 | 70.2 K to 20.2 K (-71.22 %) |
| Jun 22 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Sell | S | 33.00 | 50,000 | 1,650,000 | 70,208 | 120.2 K to 70.2 K (-41.59 %) |
| Jun 22 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 3.61 | 100,000 | 361,000 | 120,208 | 20.2 K to 120.2 K (+494.85 %) |
| Jun 21 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 4,715 | 34,797 | 56,750 | |
| Jun 21 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 32.85 | 4,715 | 154,888 | 1,354 | 6.1 K to 1.4 K (-77.69 %) |
| Jun 21 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 4,715 | 34,797 | 6,069 | 1.4 K to 6.1 K (+348.23 %) |
| Jun 16 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 285 | 2,103 | 61,465 | |
| Jun 16 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 32.85 | 285 | 9,362 | 1,354 | 1.6 K to 1.4 K (-17.39 %) |
| Jun 16 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 285 | 2,103 | 1,639 | 1.4 K to 1.6 K (+21.05 %) |
| Jun 16 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 3.61 | 39,200 | 141,512 | 156,887 | |
| Jun 16 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 3.61 | 6,604 | 23,840 | 4,196 | |
| Jun 16 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Sell | S | 32.50 | 45,804 | 1,488,630 | 20,208 | 66 K to 20.2 K (-69.39 %) |
| Jun 16 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 3.61 | 39,200 | 141,512 | 66,012 | 26.8 K to 66 K (+146.20 %) |
| Jun 16 2011 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 3.61 | 6,604 | 23,840 | 26,812 | 20.2 K to 26.8 K (+32.68 %) |
| Jun 02 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 5,000 | 36,900 | 61,750 | |
| Jun 02 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 32.39 | 5,000 | 161,950 | 1,354 | 6.4 K to 1.4 K (-78.69 %) |
| Jun 02 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 5,000 | 36,900 | 6,354 | 1.4 K to 6.4 K (+369.28 %) |
| Jun 02 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 19.85 | 15,000 | 297,750 | 45,000 | |
| Jun 02 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 8.43 | 12,500 | 105,375 | 25,000 | |
| Jun 02 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 9.08 | 7,500 | 68,063 | 0 | |
| Jun 02 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 11.94 | 6,500 | 77,610 | 0 | |
| Jun 02 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Sell | S | 31.72 | 45,250 | 1,435,276 | 1,083 | 46.3 K to 1.1 K (-97.66 %) |
| Jun 02 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 19.85 | 15,000 | 297,750 | 46,333 | 31.3 K to 46.3 K (+47.87 %) |
| Jun 02 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 8.43 | 12,500 | 105,375 | 31,333 | 18.8 K to 31.3 K (+66.37 %) |
| Jun 02 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 9.08 | 7,500 | 68,063 | 18,833 | 11.3 K to 18.8 K (+66.18 %) |
| Jun 02 2011 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 11.94 | 6,500 | 77,610 | 11,333 | 4.8 K to 11.3 K (+134.49 %) |
| May 31 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 5,000 | 36,900 | 66,750 | |
| May 31 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 5,000 | 36,900 | 71,750 | |
| May 31 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 31.93 | 5,000 | 159,650 | 1,354 | 6.4 K to 1.4 K (-78.69 %) |
| May 31 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 5,000 | 36,900 | 6,354 | 1.4 K to 6.4 K (+369.28 %) |
| May 31 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 31.47 | 5,000 | 157,350 | 1,354 | 6.4 K to 1.4 K (-78.69 %) |
| May 31 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 5,000 | 36,900 | 6,354 | 1.4 K to 6.4 K (+369.28 %) |
| May 26 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 5,000 | 36,900 | 76,750 | |
| May 26 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 31.01 | 5,000 | 155,050 | 1,354 | 6.4 K to 1.4 K (-78.69 %) |